Literature DB >> 2507925

Restoration of normal function in genetically defective myotubes by spontaneous fusion with fibroblasts.

N Chaudhari1, R Delay, K G Beam.   

Abstract

Muscular dysgenesis in mice is a genetic disease of skeletal muscle caused by the recessive mutation mdg. Muscle fibres in affected mice are paralysed because of the failure of excitation-contraction coupling. Unlike normal myotubes in primary culture, dysgenic myotubes do not contract, either spontaneously or in response to electrical stimulation. The deficiency results from mutation of the gene for the skeletal muscle dihydropyridine receptor, an essential sarcolemmal component both of excitation-contraction coupling and of the slow calcium-ion channel. It has recently been shown that the addition of fibroblasts from normal (but not dysgenic) mice to cultures of dysgenic myotubes can restore spontaneous contractions in a small fraction of these myotubes, but the mechanism for this 'rescue' was not determined. In principle, if fibroblast nuclei were able to incorporate into myotubes, such nuclei could then supply the missing muscle-specific gene product. We have now investigated this possibility using nuclear, cytoplasmic and plasmalemmal markers. We report that the rescue to contractile ability in genetically paralysed dysgenic muscle is mediated by the previously unrecognized ability of fibroblasts to fuse spontaneously with developing myotubes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507925     DOI: 10.1038/341445a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  10 in total

1.  Dermal fibroblasts participate in the formation of new muscle fibres when implanted into regenerating normal mouse muscle.

Authors:  D Pye; D J Watt
Journal:  J Anat       Date:  2001-02       Impact factor: 2.610

Review 2.  Re-evaluation of fibroblasts and fibroblast-like cells.

Authors:  T Komuro
Journal:  Anat Embryol (Berl)       Date:  1990

3.  Cooperation between the products of different nuclei in hybrid myotubes produces localized acetylcholine receptor clusters.

Authors:  H Gordon; E Ralston; Z W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Harnessing the therapeutic potential of myogenic stem cells.

Authors:  Jason D White; Miranda D Grounds
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

5.  Effects of stress hormone cortisol on the mRNA expression of myogenenin, MyoD, Myf5, PAX3 and PAX7.

Authors:  Muthuraman Pandurangan; Hemalatha Moorthy; Ravikumar Sambandam; Vikramathithan Jeyaraman; Ganesh Irisappan; Ramkumar Kothandam
Journal:  Cytotechnology       Date:  2013-10-10       Impact factor: 2.058

6.  Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation.

Authors:  Emanuela Gussoni; Richard R Bennett; Kristina R Muskiewicz; Todd Meyerrose; Jan A Nolta; Irene Gilgoff; James Stein; Yiu-Mo Chan; Hart G Lidov; Carsten G Bönnemann; Arpad Von Moers; Glenn E Morris; Johan T Den Dunnen; Jeffrey S Chamberlain; Louis M Kunkel; Kenneth Weinberg
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  MyoD-positive myoblasts are present in mature fetal organs lacking skeletal muscle.

Authors:  J Gerhart; B Bast; C Neely; S Iem; P Amegbe; R Niewenhuis; S Miklasz; P F Cheng; M George-Weinstein
Journal:  J Cell Biol       Date:  2001-10-29       Impact factor: 10.539

8.  Contractions of dysgenic skeletal muscle triggered by a potentiated, endogenous calcium current.

Authors:  B A Adams; K G Beam
Journal:  J Gen Physiol       Date:  1991-04       Impact factor: 4.086

9.  Dihydropyridine receptor alpha subunits in normal and dysgenic muscle in vitro: expression of alpha 1 is required for proper targeting and distribution of alpha 2.

Authors:  B E Flucher; J L Phillips; J A Powell
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

10.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.

Authors:  T A Rando; H M Blau
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.